SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Wix turns to $2 billion buyback to shore up confidence after stock slump

WSC Sports acquires UK sponsorship platform Partnerbrite in $10 million deal

Backed by SentinelOne, Mesh Security raises $12 million Series A to unify fragmented enterprise cyber tools

After a near reset, Adaptive6 secures $28 million Series A to tackle cloud waste

Buzz

Most popular

Daily

Weekly

1

Israel orders $183 million in air-to-ground bombs from Elbit

2

Intel employees receive 1.8-month bonus in rebound from last year’s cut

3

“SaaS is dying as a business category”

4

Factify raises $63 million in Seed funding to kill the PDF and build a new document standard for AI

5

“We built monday in four hours using our system”

Converge Bio

3 stories about Converge Bio

Converge Bio מפתחת פלטפורמת בינה מלאכותית לגילוי ופיתוח תרופות

Converge Bio raises $25 million Series A to accelerate AI drug discovery

The funding brings total investment to $30 million as the startup works with pharma partners on antibody design and protein optimization.

Converge Bio founders

Converge Bio raises $5.5M in Seed funding to speed up drug discovery and development with GenAI

The Israeli startup's platform uses large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotech and pharmaceutical companies discover and develop better-performing drugs in less time.

Intel Ignite Cohort 9

Intel Ignite announces ninth Israel cohort for early-stage deep tech startups

02.05.24|James Spiro

The startups span cross-discipline technologies for developing, deploying, and utilizing AI and generative AI across industries